Containing Or Obtained From Camellia (e.g., Tea, Including Green Or Black Tea, Etc.) Patents (Class 424/729)
-
Publication number: 20120183614Abstract: Provided are a polyphenol compound absorption promoter which is widely applicable to foods and drinks over a wide range, and a method for producing a food, drink or food material containing a polyphenol compound. The polyphenol compound absorption promoter comprises, as the active ingredient, at least one member selected from the group consisting of serine, aspartic acid, malic acid, capric acid, lauric acid, grapefruit juice and Camellia sinensis (L.) O. Kuntze extract. The method for producing a food, drink or food material containing a polyphenol compound comprises: adding at least one member selected from the group consisting of serine, aspartic acid, malic acid, capric acid, lauric acid, grapefruit juice and Camellia sinensis (L.) O.Type: ApplicationFiled: October 6, 2009Publication date: July 19, 2012Inventors: Koji Yanae, Shinpei Kawakami, Masatoshi Kato, Yuko Setoguchi, Masanori Sugitani
-
Patent number: 8221805Abstract: An antioxidant-promoting composition that increases antioxidant defense potential in a subject is disclosed comprising Bacopa monniera extract; milk thistle extract, ashwagandha powder, green tea extract, Gotu kola powder, Ginko biloba leaf extract; Aloe vera powder; turmeric extract; and N-acetyl cysteine. The antioxidant-promoting composition of the invention safely induces cellular antioxidant potential to achieve an overall net decrease in oxidative stress without the undesirable side-effects associated with the individual components of the antioxidant-promoting composition. Also disclosed is a method for reducing the undesirable side-effects of free radicals in a subject by administering to a subject in need of such antioxidants an effective amount of antioxidant-promoting composition of the invention.Type: GrantFiled: March 2, 2011Date of Patent: July 17, 2012Assignee: Lifeline Nutraceuticals CorporationInventors: Paul R. Myhill, William J. Driscoll
-
Patent number: 8221803Abstract: The present invention provides an effective, all-natural, non-toxic, non-hormonal composition consisting of vitamin D3, vitamin E, selenium, green tea extract, saw palmetto berry extract, isoflavanoids, and lycopene for prostate health. The invention provides compositions and methods to prevent, alleviate, and/or treat symptoms associated with prostate conditions and diseases. The prostate health composition may be used to supplement medical treatment such as radiation therapy, chemotherapy, and hormone therapy.Type: GrantFiled: June 12, 2008Date of Patent: July 17, 2012Assignee: OncoNatural Solutions, Inc.Inventor: Jacek Pinski
-
Patent number: 8221804Abstract: The invention encompasses novel compositions containing a methylation modifying compound isolated from botanical raw materials, including a fruit of the genus Coffea, and microbial raw materials, methods of making such compositions, and methods of treating or preventing human disease using such compositions. The methylation modifying compound in botanical extracts of the present invention can dramatically increase the level of methylation of PP2A, thus increasing cognitive function, particularly in persons suffering from or prone to developing Alzheimer's disease.Type: GrantFiled: February 3, 2006Date of Patent: July 17, 2012Assignees: Signum Biosciences, Inc., Trustees of Princeton UniversityInventors: Jeffry B. Stock, Maxwell Stock, Haoming Gu, Gregory B Stock, Zhu Li, Peter Michael Wolanin
-
Publication number: 20120171156Abstract: Conventional commercial hair dyes form potent allergens and may also have irritant properties. If they were not already well established in the market and the side effects tolerated by consumers they would likely be deemed unsafe for use. The invention relates to compounds, compositions, formulations and methods for reducing, avoiding or eliminating allergic contact dermatitis reactions to conventional commercial hair dyes.Type: ApplicationFiled: June 17, 2010Publication date: July 5, 2012Inventors: David Basketter, John McFadden, Ian White
-
Publication number: 20120156150Abstract: Disclosed is a composition for whitening skin or improving skin wrinkles comprising black tea extract as an active ingredient. In a cell experiment for Melan-a cells and an animal experiment using the brown guinea pig model with artificial tanning spots induced by UVB, the black tea extract of the present disclosure greatly inhibited melanin synthesis. Also, in an experiment on SKH-1 hairless mouse, it remarkably inhibited wrinkle formation. Accordingly, the composition of the present disclosure can be developed as a skin whitening agent, an anti-wrinkle agent or a medicine for treating diseases associated with melanin hyperpigmentation, e.g. liver spots, freckles, senile spots or solar lentigo.Type: ApplicationFiled: October 20, 2011Publication date: June 21, 2012Applicant: Keimyung University Industry Academic Cooperation FoundationInventors: Young Chul Kim, So Young Choi, Kyung Ok Lee, Teresa Jeon
-
Publication number: 20120156272Abstract: The invention is related to a composition comprising vegetable extract, carbohydrate and phospholipid for cosmetic, pharmaceutical or dietary application.Type: ApplicationFiled: February 24, 2012Publication date: June 21, 2012Applicant: Lipoid GmbHInventor: Herbert REBMANN
-
Patent number: 8202512Abstract: A combination of chemical agents reduces reductive stress by limiting the accumulation of high-energy electrons potentially available to the electron transport chain. A method of metabolic uncoupling therapy comprises: analyzing a specific physiologic process involving reductive stress; identifying a plurality of MUT agents that modulate metabolic pathways by influencing electron flux; and formulating a combination of MUT agents that limits the accumulation of high-energy electrons potentially available to the electron transport chain.Type: GrantFiled: August 4, 2011Date of Patent: June 19, 2012Inventor: Edward Larry McCleary
-
Publication number: 20120148651Abstract: According to one embodiment, a coagulant comprising calcium nitrate and an antimicrobial agent is disclosed. The coagulant may be used in the molding process to releasably bond the substrate material to the mold and to bond to the antimicrobial to the substrate material.Type: ApplicationFiled: December 10, 2010Publication date: June 14, 2012Applicant: MEDLINE INDUSTRIES INC.Inventors: Samuel T. Amdur, Min Yao
-
Publication number: 20120148685Abstract: The present invention relates to compositions comprising (i) an activator of transport of fatty acids into the mitochondria; (ii) an activator of fatty acid oxidation; and (iii) an inhibitor of fatty acid biosynthesis, and methods for treating insulin resistance, diabetes mellitus type 2, metabolic syndrome, dyslipidemias, obesity, and/or cardiovascular disorders in a subject.Type: ApplicationFiled: June 10, 2010Publication date: June 14, 2012Applicant: Engergy4Life AGInventor: Markus Rohner
-
Patent number: 8197865Abstract: The present invention relates to compositions and methods for modulating hair growth or regrowth. The compositions of the present invention include extracts of one or more of the following: Boswellia serrata, Undaria pinnatifida, green tea (e.g., Camellia sinensis), shiso, Pureraria mirifica, luteolin (e.g. Perilla ocymoides leaf extract), astilbin, vitamin E, amentoflavone, tetrahydropiperine, lichochalcone, astaxanthin, red clover, Brassica juncea, unfermented green rooibos, enzyme CoQ10, salvia, ximenynic acid, hops oleoresin, apple, soy, saw palmetto, or ellagic extract, or any derivative thereof.Type: GrantFiled: October 11, 2010Date of Patent: June 12, 2012Assignee: Access Business Group International LLCInventors: Kelly M. Glynn, Lane A. Duvel, David M. Flower
-
Patent number: 8197867Abstract: Of three layers, the first layer in a rapid release composition of a plurality of thermogenic constituents is about 40 percent by weight of the system plus or minus 10 percent. The second layer in a delayed release composition of energy and thyroid stimulating constituents is about 40 percent by weight of the system plus or minus 10 percent. The third layer in a sustained release composition of fat binding and appetite suppressing constituents is 20 percent by weight of the system plus or minus 10 percent.Type: GrantFiled: February 7, 2008Date of Patent: June 12, 2012Inventor: Richard Blackford
-
Publication number: 20120141446Abstract: A composition for increasing the bioavailability of nutrients in humans and animals comprising an oil base emulsion into which nutrients selected from the group comprising omega fatty acids, vitamin D, Co Q10, green tea extract, and policosanol are added.Type: ApplicationFiled: December 2, 2010Publication date: June 7, 2012Inventor: Bhiku Patel
-
Publication number: 20120141387Abstract: The present invention relates to a composition, notably cosmetic, nutraceutical, dermatological, pharmaceutical or dietary, including at least one unsaponif iable extract, a drug including one such composition, the use of one such composition, a treatment method consisting in administering one such composition and a method comprising the administration of one such composition.Type: ApplicationFiled: August 12, 2010Publication date: June 7, 2012Inventors: Philippe Msika, David Daguet
-
Publication number: 20120141614Abstract: A carotenoid substance called zeaxanthin, when ingested orally at suitable dosages such as 30 to 100 mg/day for a span of 1 to 2 weeks, can provide effective protection against sunburns, and can give skin a darker tint that emulates a healthy suntan. In tests involving adults, it was found that zeaxanthin dosages of 30 to about 80 mg per day were sufficient to induce: (i) a mild but noticeable tinting, shading, or darkening of skin color, comparable to a mild suntan; (ii) a substantial increase in the person's ability to withstand elevated levels of sun or UV exposure; and, (iii) an increased ability of reddened and sunburned skin to convert into intact skin that looks browned and healthily tanned. Oral ingestion of dosages of zeaxanthin after a noticeable darkening of the skin has been achieved further enhances a tanned appearance and/or protects against sun damage.Type: ApplicationFiled: December 1, 2011Publication date: June 7, 2012Applicant: ZeaVision LLCInventors: Dennis L. Gierhart, Joseph A. Fox
-
Patent number: 8192768Abstract: Disclosed herein are novel dietary supplement compositions comprising enriched 3-O-acetyl-11-keto-?-boswellic acid and enriched demethylated curcuminoids, wherein the composition exhibits anti-inflammatory, antiulcerogenic and antioxidant activities. Also disclosed are novel compositions comprising enriched 3-O-acetyl-11-keto-?-boswellic acid, enriched demethylated curcuminoids that have a synergistic effect on specific inhibition of—COX-2 and 5-LOX activity and optionally containing glucosamine, resveratrol, garlic extract, chondroitin, methlysulphonymethane, bromelain, serratiopeptidase, quercitine, gallic acid, caffeic acid, green tea extract, aspirin and ibuprofen.Type: GrantFiled: April 3, 2007Date of Patent: June 5, 2012Assignee: Laila ImpexInventors: Ganga Raju Gokaraju, Rama Raju Gokaraju, Trimurtulu Golakoti, Vendateswarlu Somepalli
-
Publication number: 20120128800Abstract: A dietary supplement composition comprising aronia extract containing at least 20% anthocyanins by dry weight. The aronia extract is derived from the aronia melanocarpa plant. The aronia extract comprises approximately 10%-30% of the dry weight of the composition. A vitamin, weight loss agent, or antioxidant is provided in the composition. The dietary supplement composition is administered orally to promote weight loss.Type: ApplicationFiled: November 28, 2011Publication date: May 24, 2012Applicant: FHG Corporation d/b/a Integrity NutraceuticalsInventors: Timothy J. Romero, Bolin Qin, Peter J. Miller
-
Publication number: 20120121721Abstract: Disclosed herein is a composition for treating maladies in humans or animals that includes from about 0.01% to about 40% by weight of a member of the curcuma genus, from about 0.01% to about 40% by weight of a member of the coffea genus and the balance being a pharmaceutically acceptable carrier.Type: ApplicationFiled: November 16, 2010Publication date: May 17, 2012Inventor: Michael James
-
Publication number: 20120093894Abstract: Disclosed herein are stable oil-in-water emulsion ophthalmic topical liquid compositions having an average particle size less than 1 ?m including at least one plant-derived oil other than castor oil wherein the oil comprises only aliphatic side chains free of polar pendent groups. The oil-in-water emulsion ophthalmic topical liquid compositions also include a hydrophilic surfactant having an HLB value between approximately 10 and 14, a vegetable oil-derived hydrophobic non-co-block surfactant having unsaturated side chains that contain less than four oxygen atoms having an HLB value between approximately 4 and 6 and is a liquid at room temperature. The oil-in-water emulsion ophthalmic topical liquid compositions disclosed herein can further include an amount of cyclosporine A or polyphenol in an amount effective to relieve dry eye symptoms.Type: ApplicationFiled: June 2, 2010Publication date: April 19, 2012Applicant: Abbott Medical Optics Inc.Inventors: Zhi-Jian Yu, Stanley W. Huth, Stephen J. Demichele
-
Publication number: 20120087996Abstract: Antioxidant skin care composition comprising at least two antioxidant components one of which is a solid coffee extract antioxidant, which exhibits a synergistically increased antioxidant potency as measured by ORACsc compared to the antioxidant potency of antioxidant skin care compositions which do not contain at least two antioxidant components one of which is a solid coffee extract antioxidant. The skin care compositions are particularly suited for use in the treatment of wrinkles, pigmentation effects caused by sun damage and redness in the skin.Type: ApplicationFiled: October 8, 2010Publication date: April 12, 2012Inventor: Debbie M. Palmer
-
Publication number: 20120089105Abstract: The present invention relates to a skin patch comprising a matrix adhering to the skin and containing at least one active cosmetic substance and a combination with a skin wrapping to generate an effective compression for the treatment of cellulite and/or striae.Type: ApplicationFiled: December 16, 2011Publication date: April 12, 2012Applicant: BEIERSDORF AGInventors: Soeren JASPERS, Carsten HARTKOPF, Christian GAEDE, Stefan BODENSCHATZ, Katharina POST, Jens SCHULZ, Karl-Heinz WOELLER
-
Publication number: 20120070386Abstract: The present invention relates to a trehalulose-containing composition, its preparation and use.Type: ApplicationFiled: April 15, 2010Publication date: March 22, 2012Inventors: Wolfgang Wach, Thomas Rose, Michael Klingeberg, Siegfried Peters, Tillmann Dörr, Stephan Theis, Jorg Kowalczyk, Stephan Hausmanns
-
Patent number: 8137713Abstract: Oral composition comprising a Camellia extract of semi-oxidized tissue from a member of the genus Camellia and an enhancing agent.Type: GrantFiled: April 7, 2008Date of Patent: March 20, 2012Assignee: Colgate-Palmolive CompanyInventors: Thomas J. Boyd, Abdul Gaffar, David Viscio
-
Publication number: 20120063996Abstract: The present invention provides nanoparticulate nimesulide compositions. The compositions preferably comprise nimesulide and at least one surface stabilizer adsorbed on or associated with the surface of the nimesulide particles. The nanoparticulate nimesulide particles preferably have an effective average particle size of less than about 2000 nm. The invention also provides methods of making and using nanoparticulate nimesulide compositions.Type: ApplicationFiled: July 28, 2011Publication date: March 15, 2012Inventors: H. William Bosch, Christian F. Wertz
-
Publication number: 20120058140Abstract: A topical composition according to the present invention for use in a skin care regimen that provides matrix metalloprotease (MMP) inhibiting activity, tissue inhibitor of metalloprotease (TIMP) inducing activity, and immediate and delayed antioxidative activity. Preferably, the topical composition comprises at least one MMP inhibitor, a TIMP inducing agent, Tremella fuciformis (snow fungus) extract, Camellia sinensis (green tea) leaf extract, and Eugenia caryophyllus (clove) extract. The compositions are useful in anti-wrinkle and anti-aging products, providing elasticity, firmness, tone and texture to the skin, ameliorating fine lines and preventing skin damage.Type: ApplicationFiled: September 2, 2010Publication date: March 8, 2012Applicant: Bath & Body Works Brand Management, Inc.Inventors: Joseph D. Ceccoli, Brian Costello, James A. Hayward, Konstantinos M. Lahanas
-
Publication number: 20120052138Abstract: The present invention relates to a composition containing a green tea extract as an active ingredient. The composition is effective in treating or preventing obesity and the like and can be beneficially employed in various ways in fields such as foodstuffs and medicine.Type: ApplicationFiled: May 19, 2010Publication date: March 1, 2012Inventors: Pil Joon Park, Chae Wook Kim, Eui Seok Shin, Si Young Cho, Lang Gook Yoo, Yu Jin Oh, Dae Bang Seo, Chan Su Rha, Jin Oh Chung, Sang Jun Lee
-
Publication number: 20120052137Abstract: A weight loss product comprises a mixture of Alchemilla vulgaris, Olea europaea, Cuminum cyminum, and Mentha longiflora (in the weight proportion 12:10:5:4), to which additional ingredients have been added to increase weight loss efficacy.Type: ApplicationFiled: August 30, 2011Publication date: March 1, 2012Applicant: NORTHERN INNOVATIONS AND FORMULATIONS CORP.Inventors: Shawn Shirazi, James Akrong, Phil Apong, Raza Bashir, Craig Wissent
-
Patent number: 8124141Abstract: Topical compositions, and particularly hydrophobic compositions include an essential oil in an amount effective to achieve substantially complete absorption of the composition in the skin without leaving a greasy residue. Especially preferred topical compositions may also include pharmaceutically active agents (e.g., polyphenol), additional essential oils, stabilizers, etc. In further preferred aspects, contemplated compositions may delay onset, or even prevent viral eruptions on the skin, and where applied as a lipstick, will increase reddening of the lip as well as reduce chapping.Type: GrantFiled: March 4, 2004Date of Patent: February 28, 2012Assignees: Mitsui Norin Co., Ltd., Epitome Pharmaceuticals LimitedInventors: Paul T. Wegener, Yukihiko Hara
-
Publication number: 20120045404Abstract: The present invention relates to isolated bioactive compositions containing bioactive fractions derived from Theacea plants. The present invention also relates to bioactive topical formulations containing the bioactive compositions. The present invention further relates to methods of using the bioactive compositions of the present invention, including, for example, methods for inhibiting inflammatory activity in skin tissue of a mammal, for protecting skin tissue of a mammal from ultraviolet light-induced damage, and for normalizing skin disorders in skin tissue of a mammal. The present invention also relates to methods for isolating bioactive fractions derived from cell juice or a cell walls component a Theacea plant.Type: ApplicationFiled: October 24, 2011Publication date: February 23, 2012Applicant: AKZO NOBEL SURFACE CHEMISTRY LLCInventor: Michael KOGANOV
-
Publication number: 20120039980Abstract: Methods of preventing adhesion between issues are provided that utilizes in situ crosslinked biomaterials. The biomaterial contains at least the crosslinked product of two biocompatible, non-immunogenic components having reactive groups thereon, with the functional groups selected so as to enable inter-reaction between the components, i.e., crosslinking. Exemplary uses for the crosslinked compositions include preventing adhesions following surgery or injury, and preventing scar tissue formation.Type: ApplicationFiled: October 24, 2011Publication date: February 16, 2012Inventors: George Y. Daniloff, Louis C. Sehl, Olof Mikael Trollsas, Jacqueline Schroeder, David M. Gravett, Philip M. Toleikis
-
Patent number: 8114446Abstract: The inventive subject matter relates to methods for modulating an eicosanoid metabolic process in cells of an animal in need thereof, which comprises administering to the animal an amount of the inventive compositions effective for regulating the activity of an eicosanoid oxygenase. In particular, the inventive subject matter relates to methods for modulating arachadonic acid metabolism by administering an amount of the inventive compositions effective for regulating the activity of lipoxygenases and cyclooxygenases.Type: GrantFiled: June 29, 2010Date of Patent: February 14, 2012Assignees: New Chapter Inc., Board Of Regents Of The University Of Texas SystemInventors: Thomas Newmark, Paul Schulick, Robert Newman, Bharat Aggarwal
-
Personal Care Compositions Comprising A Multi-Active System For Down Regulating Cytokines Irritation
Publication number: 20120035557Abstract: A personal care composition comprising a multi-active system for down regulating cytokines comprising at least three actives, an extract of camellia sinesis, panthenol, and a glycyrrhizinate salt.Type: ApplicationFiled: July 1, 2011Publication date: February 9, 2012Inventors: Timothy Woodrow Coffindaffer, Benjamin Parker Heath, Helen Rochelle Kemp, Robert John Willicut -
Publication number: 20120027787Abstract: A composition of matter comprises a shelf stable, super critical, CO2 fluid extracted seed oil derived from a cracked biomass of perilla frutescens, the seed oil comprising from about 60 to about 95 percent w/w of PUFAs in a ratio of from about 4:1 to about 6:1 alpha-linolenic acid (ALA) to linoleic acid (LA) and a mixture of selected antioxidants.Type: ApplicationFiled: September 13, 2011Publication date: February 2, 2012Applicant: U.S. Nutraceuticals, LLC d/b/a Valensa InternationalInventors: John A. Minatelli, W. Stephen Hill, Rudi E. Moerck, Uy Nguyen
-
Patent number: 8101216Abstract: The present invention relates to a skin patch comprising a matrix adhering to the skin and containing at least one active cosmetic substance and a combination with a skin wrapping to generate an effective compression for the treatment of cellulite and/or striae.Type: GrantFiled: March 29, 2006Date of Patent: January 24, 2012Assignee: Beiersdorf AGInventors: Soeren Jaspers, Carsten Hartkopf, Christian Gaede, Stefan Bodenschatz, Katharina Post, Jens Schulz, Karl-Heinz Woeller
-
Publication number: 20120015057Abstract: Provided is a polyphenol composition derived from Camellia sinensis and having reduced harshness. The polyphenol composition according to the invention is derived from Camellia sinensis and contains flavonol aglycones and flavonol glycosides. A weight ratio [(B)/(A)] of the following total contents (B) to (A) is from 0.01 to 18: (A) total content of the flavonol aglycones contained in solids of the polyphenol composition after hydrolysis as measured by high-performance liquid chromatography, and (B) total content of the polyphenols contained in solids of the polyphenol composition as measured by the ferrous tartrate method.Type: ApplicationFiled: March 17, 2010Publication date: January 19, 2012Applicant: KAO CORPORATIONInventors: Susumu Ohishi, Norihiko Satake, Tomoko Konishi, Shinichiro Takashima
-
Publication number: 20120015021Abstract: Compositions for appetite suppression and methods of making and using thereof are disclosed herein. The compositions are typically in the form of a tablet, such as a single or multi-layer sticker tablet. The compositions adhere to a buccal surface or mucosal surface in the oral cavity for at least 15 minutes, preferably for at least 30 minutes. In a preferred embodiment, the compositions contain herbal agents that are anti-appetite agents. The composition is generally effective for suppressing appetite for a time period ranging from at least 30 minutes up to eight hours following administration to the buccal or oral mucosa.Type: ApplicationFiled: July 13, 2010Publication date: January 19, 2012Inventors: Boaz Mizrahi, Benny Brama, Abraham J. Domb
-
Patent number: 8097286Abstract: Herbal extracts composition suitable for weight management in mammals is disclosed. The composition comprises a mixture of Garcinia extract, Green tea extract, Green coffee extract and Banaba extract. The method of reducing weight, and treating diabetes in mammals involve oral administration of the composition. The invention further relates to a method of producing and standardizing the individual extract useful for human health.Type: GrantFiled: November 3, 2006Date of Patent: January 17, 2012Assignee: Inqpharm SDN BHDInventors: Philip Samuel, Fred Pescatore
-
Patent number: 8092840Abstract: A nutritional supplement for enhancing sleep and lucid dreaming in humans. It contains a combination of ingredients in proportions calculated to enhance lucid dreaming. The primary ingredients are Calea ternifolia, L-5-Hydroxytryptophan (L-5-HTP), and Vinpocetine. In addition, the nutritional supplement may include the secondary ingredient Melatonin and the tertiary ingredients Wild Lettuce Extract, Mugwort Extract, Dimethylaminoethanol Powder (DMAE), Passionflower Extract and Green Tea Extract. Further, various Vitamins may be added such as certain B vitamins, D and C, as well as Zinc, Magnesium and Calcium. The selection and amounts of the ingredients of the nutritional supplement promotes sleep and lucid dreaming in people who have taken the nutritional supplement prior to going to sleep.Type: GrantFiled: October 30, 2007Date of Patent: January 10, 2012Inventor: Jeff Luciano
-
Publication number: 20120003300Abstract: A composition to treat hair loss and enhance hair growth and condition. The composition comprises: i) one or more of VEGF, a VEGF biomimetic peptide, and/or a VEGFR2 receptor agonist; ii) ciclopirox olamine; and iii) a pharmaceutically acceptable carrier.Type: ApplicationFiled: June 30, 2011Publication date: January 5, 2012Inventors: Elliot Isaacs, Toby Cobbledick
-
Publication number: 20120003292Abstract: Provided, among other things, is a slowly dissolvable film comprising: herbal bioactive agent(s); and polymer(s), dissolvable in the aggregate, wherein the film becomes adhesive as it is placed against a mucosal surface and begins to absorb moisture therefrom.Type: ApplicationFiled: September 19, 2011Publication date: January 5, 2012Inventors: Zvi G. Loewy, William Zev Levine, Aron J. Saffer
-
Publication number: 20110318434Abstract: An improved method, formulation and kit for the treatment of acne vulgaris are disclosed. The formulation is effective in inhibiting or killing the Proprionibacterium microorganism without utilizing antibiotics A preferred formulation alleviates the four pathogenic factors involved in the development of acne a) the putative pathogen of acne, Proprionibacterium acnes, b) abnormal desquamation of sebaceous-follicle epithelium (comedogenesis), c) the androgen-induced excessive sebum production, and d) the follicular reactivity (inflammation). The formulations are preferably applied as a cream, lotion or an emulsion.Type: ApplicationFiled: December 17, 2009Publication date: December 29, 2011Inventor: B. Eugene Guthery
-
Publication number: 20110311658Abstract: A topical composition comprising at least one active agent selected from a depilatory agent (s), an agent (s) for preventing or reducing the growth or re-growth of hair and an agent (s) for preventing or reducing in-growing hair, and a gas, wherein the at least one active agent and gas are dispersed in a cosmetically acceptable medium.Type: ApplicationFiled: January 15, 2010Publication date: December 22, 2011Applicant: Reckitt & Colman (Overseas) LimitedInventors: Magali Bertrand, Philippe Henriat
-
Publication number: 20110305744Abstract: A preparation for vaginal and rectal use comprising hyaluronic acid, with an average particle size comprised between about 50 micrometers and about 200 micrometers and a molecular weight comprised between about 1,000,000 Da and about 1,800,000 Da.Type: ApplicationFiled: September 8, 2010Publication date: December 15, 2011Applicant: FARMA-DERMA SRLInventor: Vincenzo Russo
-
Patent number: 8076314Abstract: A pharmaceutical composition for treatment of skin aging including a pharmaceutically effective amount of estriol; a pharmaceutically effective amount of estradiol; a pharmaceutically effective amount of hyaluronic acid; a pharmaceutically effective amount of green tea extract; and a pharmaceutically acceptable carrier is provided. In some embodiments, the composition further includes ascorbic acid, date palm extract, or a combination thereof. Also disclosed is a method for treating symptoms of skin aging and photoaging by administering a pharmaceutical composition having estriol, estradiol, hyaluronic acid, green tea extract, a pharmaceutically acceptable carrier and optionally, ascorbic acid and date palm extract. A method of promoting urogenital function is likewise provided wherein a pharmaceutical composition having estriol, estradiol, hyaluronic acid, and green tea extract is applied intravaginally.Type: GrantFiled: July 7, 2010Date of Patent: December 13, 2011Assignee: MCKA, LLCInventors: Stephanie N. McClellan, Ashton A. Kaidi
-
Patent number: 8075926Abstract: The present invention provides therapeutic compositions comprising extracts of the plant species Echinacea purpurea and Sambucus nigra and the extract(s) of at least one further plant selected from the group consisting of Hypericum perforatum, Commiphora molmol and Centella asiatica. The compositions of the invention are of particular utility in the management of inflammatory mucosal diseases of both viral and non-viral origin.Type: GrantFiled: April 2, 2009Date of Patent: December 13, 2011Assignee: Izun Pharmaceuticals CorporationInventors: William Z. Levine, Aron J. Saffer, Mina Fran
-
Publication number: 20110300227Abstract: Methods, compositions, and strategies for the treatment of malignant neoplasms are presented herein. The treatment modalities are directed towards exploiting characteristics of cancer cells as well as correcting defective biochemical pathways and systems in the body.Type: ApplicationFiled: May 20, 2011Publication date: December 8, 2011Applicant: NORTH TEXAS MEDICAL ASSOCIATESInventor: Ivan E. Danhof
-
Publication number: 20110300241Abstract: Disclosed herein are oral care compositions for promoting salivary flow. Thus, also disclosed are methods of treating and preventing xerostomia. The oral care compositions can contain all-natural ingredients, including, for example, green tea polyphenols and jaborandi extract.Type: ApplicationFiled: February 22, 2010Publication date: December 8, 2011Applicant: Medical College of Georgia Research Institute, IncInventor: Stephen D. Hsu
-
Publication number: 20110300085Abstract: The present invention relates to home and personal care compositions comprising a silicone oil-in-water emulsion stabilized by a protein or peptide and at least one home and/or personal care ingredient. Such compositions tend to provide desirable characteristics for the care and conditioning of hair, skin and fabric.Type: ApplicationFiled: October 30, 2009Publication date: December 8, 2011Inventors: Emilie Courbon, Lorry Deklippel, Tatiana Dimitrova, Anne-Lise Girboux, Sophie Hanssens, Stephane Ugazio
-
Publication number: 20110293535Abstract: Composition intended for buccal absorption of nicotine into the system circulation and distribution to the central nervous system for the purpose of smoking cessation or nicotine substitution in conditions adverse for smoking according to the invention contains nicotine solution in form of a base and/or its salt with organic acid in concentration 0.01 to 8.00% by weight and substances with mucolytic effect. Single application dosage contains 0.05 to 3.00 mg of nicotine.Type: ApplicationFiled: February 3, 2010Publication date: December 1, 2011Applicant: Heglund, A.S.Inventors: Dobromil Kosik, Milan Dittrich
-
Publication number: 20110293588Abstract: A combination of chemical agents reduces reductive stress by limiting the accumulation of high-energy electrons potentially available to the electron transport chain. A method of metabolic uncoupling therapy comprises: analyzing a specific physiologic process involving reductive stress; identifying a plurality of MUT agents that modulate metabolic pathways by influencing electron flux; and formulating a combination of MUT agents that limits the accumulation of high-energy electrons potentially available to the electron transport chain.Type: ApplicationFiled: August 4, 2011Publication date: December 1, 2011Inventor: Edward Larry McCleary